Robin Zhang, PhD
Associate Director, China Regulatory Submissions
Robin Zhang, PhD is an Associate Director of China Regulatory Submissions at Fortrea with 20 years of experience in regulatory affairs and project management within the pharmaceutical industry. He oversees a broad range of China regulatory submissions, including IND submissions and maintenance, HGRAC filings, CDE clinical trial registrations and import/export permit applications.
Robin also serves as a member of the China Regulatory Intelligence Committee, supporting regulatory monitoring and stakeholder engagements.
He has played a key role in implementing eCTD publishing in China at Fortrea, supporting tool deployment, system maintenance, and team training to strengthen in-house eCTD capabilities.
Prior to joining Fortrea in 2020, Robin was Director of a global research and development center at a major Chinese pharmaceutical company, leading regulatory affairs and global development programs. He holds both a BS and a PhD in Chemistry and Chemical Biology from Nankai University.